Related Experiment Videos
Chromosomal instability in hereditary tyrosinemia type I
E Gilbert-Barness1, L A Barness, L F Meisner
1Department of Pediatrics, University of Wisconsin Medical School, Madison 53706.
Pediatric Pathology
|January 1, 1990
Summary
Hereditary tyrosinemia type I is linked to genetic instability, increasing cancer risk. Accumulating tyrosine metabolites cause DNA damage, leading to liver cancer and organ abnormalities in affected children.
Area of Science:
- Biochemistry
- Genetics
- Pathology
Background:
- Hereditary tyrosinemia type I (HT-1) is a rare genetic disorder affecting tyrosine metabolism.
- Patients accumulate toxic intermediates, leading to severe liver and kidney disease.
Observation:
- Autopsy of a child with HT-1 revealed hepatocellular carcinoma, cirrhosis, and renal tubular dysplasia.
- Cytogenetic analysis showed significant chromosome breakage (71%) in skin fibroblasts.
Findings:
- The study links genetic instability, characterized by increased chromosome breakage, to HT-1.
- Accumulation of tyrosine catabolism intermediates (e.g., maleylacetoacetate, fumarylacetoacetate) acts as alkylating agents, causing DNA damage.
- This DNA damage is implicated in hepatoma development and dysplastic changes in non-tumorous liver tissue.
Implications:
- The findings suggest a mechanism for hepatoma development in HT-1 patients.
- Genetic instability may contribute to other observed pathologies, including renal tubular atypia and pancreatic changes.
- Understanding this link can inform strategies for managing HT-1 complications and cancer surveillance.